(Q37827752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

A new dimension of FDG-PET interpretation: assessment of tumor biology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Babak Saboury

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

6

Abass Alavi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Thomas C Kwee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Sandip Basu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Drew A Torigian

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

12 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1158-1170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

Feasibility of automated partial-volume correction of SUVs in current PET/CT scanners: can manufacturers provide integrated, ready-to-use software?

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Clinical applications of PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Causes and consequences of increased glucose metabolism of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Recommendations on the use of 18F-FDG PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Blood and tissue biomarkers in prostate cancer: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Prediction of pathology and survival by FDG PET in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

FDG-PET for management of cervical and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

PET imaging in gynecologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1713-9

The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer

21 January 2018

1 reference

12 December 2020

Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.

1 reference

12 December 2020

Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings

1 reference

12 December 2020

Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma

1 reference

12 December 2020

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

1 reference

12 December 2020

Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection

1 reference

12 December 2020

Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia

1 reference

12 December 2020

Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast Carcinoma

1 reference

12 December 2020

Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.

1 reference

12 December 2020

Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values

1 reference

12 December 2020

10.1007/S00259-010-1713-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21225422%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference